Insights

Why is the Medibank (ASX:MPL) share price struggling lately?

It hit a 52-week high in early September but the Medibank share price has been struggling ever since.
The post Why is the Medibank (ASX:MPL) share price struggling lately? appeared first on The Motley Fool Australia. –

The Medibank Private Ltd (ASX: MPL) share price has been struggling lately.

Since reaching a 52-week high of $3.62 a share back on 7 September, the Medibank share price has fallen by more than 2% to sit at $3.55 a share so far today.

Even so, the company remains up by 16.6% year to date, and up a very healthy 38.3% over the past 12 months.

But why have Medibank shares been struggling over the past week or two?

Medibank share price struggles after ex-dividend date

Well, one anchor on the Medibank share price last week was its ex-dividend date.

In Medibank’s FY21 earnings report, which it delivered last month, the company announced a final dividend for FY21 of 6.9 cents per share, fully franked.

That payment will hit investors’ pockets on 30 September. But it left the Medibank share price on 8 September when the shares went ex-dividend.

This is the primary reason why the Medibank share price has struggled ever since.

Even so, shareholders might not be too concerned. This final dividend was a boost from FY20’s final payout of 6.3 cents per share.

Another potential reason for Medibank’s recent struggle is some private health sector news.

According to a report on news.com.au this week, private health insurers like Medibank have been offering their customers ‘COVID discounts’.

The report states that “some of the largest insurers [are handing] back funds collected in premiums that didn’t get paid in claims due to Covid restrictions”.

This includes Medibank, which the report states has “also committed to returning around $105 million in Covid-19 net claims through premium relief for Australian Medibank and ahm customers with an active hospital and/or extras policy between the 2020/21 financial year”.

Whilst this news may please Medibank’s customers, it is still unquestionably deleterious to the company’s overall finances. This may have been deterring investors in recent times.

At the current Medibank Private share price of $3.55, the company has a market capitalisation of $9.78 billion. It also has a price-to-earnings (P/E) ratio of 22.16 and a dividend yield of 3.58%

The post Why is the Medibank (ASX:MPL) share price struggling lately? appeared first on The Motley Fool Australia.

Should you invest $1,000 in Medibank Private right now?

Before you consider Medibank Private, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank Private wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Why A2 Milk, Flight Centre, Medibank, & St Barbara shares are dropping

Dividends galore! 10 ASX shares trading ex-dividend on Wednesday

5 things to watch on the ASX 200 on Wednesday

Here’s why the Medibank (ASX:MPL) share price jumped 7% in a month
How does the Medibank (ASX:MPL) earnings result compare to NIB?

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!